While health plans struggle with coverage questions and the high cost of GLP-1 (glucagon-like peptide-1) drugs, there is no doubt they are not going away
Here is the solution worth understanding: carefully selected peptides, prescribed under medical oversight, can nudge your pituitary gland, hypothalamus, gut, and immune signaling back toward balance
Biotoxin Binder Support promotes microbiome balance
Todays mass use of GLP-1s has opened the door for scientists to explore other potential treatment uses for the drug, including for addiction, Alzheimers and liver, kidney and autoimmune disease
Our treatment approach targets the receptors in the brain that control appetite and lowers the bodys set point, i.e
doi: 10.2147/DDDT.S6762 11 DavisH